Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of FMT in Maintenance of Pediatric Crohn's Disease
NCT03194529Phase 2Completed
- Sponsor
- Children's Hospital Los Angeles
- Start
- Oct 2017
- Primary completion
- Jun 2019
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic fecal microbiota in Crohn's disease, sponsored by Children's Hospital Los Angeles. Started Oct 2017; status: completed.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT03194529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03194529.